Investigation of commercial lecithin by 31P NMR in a ternary CUBO solvent
โ Scribed by Mauro A Cremonini; Luca Laghi; Giuseppe Placucci
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 111 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0022-5142
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Many different ways have been devised over the years for analysing phospholipids in solution by ^31^P NMR. One promising method entails the use of the soโcalled CUBO solvent, a ternary mixture of dimethylformamide, triethylamine and guanidinium hydrochloride. As this interesting system seems to have been overlooked in the literature, we present here a study on the quantification of phospholipids and lysophospholipids contained in 10 samples of commercial lecithin using the CUBO/^31^P NMR method. Cluster analysis and principal component analysis of the NMR data showed clear differences among the samples according to the actual lecithin producer. Multivariate analysis of the chemical and physical parameters of the samples confirmed these differences. Copyright ยฉ 2004 Society of Chemical Industry
๐ SIMILAR VOLUMES
## Abstract Brain phospholipids can be quantitated by highโresolution ^31^P NMR of crude brain tissue extracts in the solvent system chloroformโmethanolโwater (+EDTA) which was introduced recently (P. Meneses and T. Glonek, __J. Lipid Res.__ 29, 679 (1988)). Phospholipid resonance positions depend
We have studied the effects of gangiiosides on the polymorphic behaviour of phosphatidylethanolamines. The ganghoside Gvla promotes the formation of phases which give rise to isotropic 31p-NMR resonance lines, particularly in the temperature range of the L, to Hit transition. In addition, higher mol
## Abstract A selective ^1^H NMR spinโecho editing method was used to detect the CCH, of GABA in rat brain __in vivo__ before and after intravenous administration of the highly selective GABA transaminase inhibitor, gabaculine (3โaminoโ2,3โdihydrobenzoic acidโHCl; 100 mg/kg, intravenously). The eff